Gabaa Receptor Positive Allosteric Modulators Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gabaa Receptor Positive Allosteric Modulators stocks.

Recent Signals

Date Stock Signal Type
2021-04-12 ABBV NR7 Range Contraction
2021-04-12 ABBV MACD Bullish Centerline Cross Bullish
2021-04-12 AQST MACD Bearish Signal Line Cross Bearish
2021-04-12 SAGE Fell Below 20 DMA Bearish
2021-04-12 SAGE Bollinger Band Squeeze Range Contraction

Recent News for Gabaa Receptor Positive Allosteric Modulators Stocks

Date Stock Title
Apr 12 AQST Rosen, Leading Trial Attorneys, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Apr 12 ESPR Esperion to Report First Quarter 2021 Financial Results May 4, 2021
Apr 12 SAGE Biogen and Sage trade lower despite positive essential tremor trial
Apr 12 AQST FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Apr 12 SAGE Sage-Biogen Essential Tremor Candidate Hits Primary Endpoint Goal, But 38% Of People Drop Out
Apr 12 ABBV AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
Apr 12 ABBV Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year?
Apr 12 SAGE Sage Stock Trips As Analysts Question Longevity Of Biogen-Partnered Drug
Apr 12 SAGE Sage Therapeutics/Biogen's SAGE-324 meets primary endpoint in essential tremor study
Apr 12 SAGE Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
Apr 12 SAGE Sage Falls as Some Patients Drop Out of Tremor Treatment Study
Apr 11 ABBV AbbVie: Buy The Humira Fear And Profit
Apr 11 ABBV 4 Green Flags for AbbVie in 2021
Apr 11 ABBV 3 Great Dividend Stocks to Buy Right Now
Apr 10 AQST ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action – AQST
Apr 10 ABBV Better Value Stock: AbbVie or Viatris?
Apr 9 AQST UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Apr 9 AQST ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors With LARGE LOSSES to Secure Counsel Before Important
Apr 9 ABBV Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes
Apr 9 SAGE Provention Bio downgraded on FDA feedback, Citi sizes up Zuranolone success on Sage, and more in today’s analyst action